The Effect of Montelukast on Liver Damage in an Experimental Obstructive Jaundice Model

BACKGROUND: Montelukast is a cysteinyl-leukotriene type 1 (CysLT(1)) selective receptor antagonist. In recent years, investigations have shown that montelukast possesses secondary anti-inflammatory activities and also antioxidant effects. For this reason, we aimed to determine the possible effects o...

Descripción completa

Detalles Bibliográficos
Autores principales: Kuru, Serdar, Kismet, Kemal, Barlas, Aziz M., Tuncal, Salih, Celepli, Pinar, Surer, Hatice, Ogus, Elmas, Ertas, Ertugrul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger Verlag für Medizin und Naturwissenschaften GmbH 2015
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4789965/
https://www.ncbi.nlm.nih.gov/pubmed/26989383
http://dx.doi.org/10.1159/000375434

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4789965/
https://www.ncbi.nlm.nih.gov/pubmed/26989383
http://dx.doi.org/10.1159/000375434

Ejemplares similares